1. Long-term safety of certolizumab pegol in rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis and Crohn's disease: a pooled analysis of 11 317 patients across clinical trials. Issue 1 (31st May 2019) Authors: Curtis, Jeffrey R; Mariette, Xavier; Gaujoux-Viala, Cécile; Blauvelt, Andrew; Kvien, Tore K; Sandborn, William J; Winthrop, Kevin; de Longueville, Marc; Huybrechts, Ivo; Bykerk, Vivian P Journal: RMD open Issue: Volume 5:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗